Stigma blocks lung cancer dollars

"Where are all the lung cancer races and ribbons? And why does the nation’s research investment in lung cancer lag behind other cancers?"
--Andrew Holtz, journalist, writing in the Nov. 10 issue of Oncology Times

Holtz’ article examines the stigma of lung cancer and how it affects research funding. He found, for example, that the National Cancer Institute spends almost nine times as much per death from breast cancer as it does per lung cancer death. Another problem for lung cancer research: Survivor advocates are in short supply because the disease is so deadly.